Related Experiment Video
Updated: Apr 23, 2026

The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice
Published on: February 3, 2012
Hepatitis C virus infection increases the risk of developing peripheral arterial disease: a 9-year population-based
Yueh-Han Hsu1, Chih-Hsin Muo2, Chun-Yi Liu3
1Department of Public Health, China Medical University, Taichung City 404, Taiwan; Department of Health Services Administration, China Medical University, Taichung City 404, Taiwan; Department of Internal Medicine, Division of Nephrology, Ditmanson Medical Foundation Chia-Yi Christian Hospital, Chia-Yi City 600, Taiwan; Department of Nursing, Min-Hwei Junior College of Health Care Management, Tainan City 736, Taiwan.
Insights
Hepatitis C virus (HCV) infection significantly increases the risk of developing peripheral arterial disease (PAD). This risk is higher in HCV patients with comorbidities and increases with age.
Area of Science:
- Vascular Medicine
- Hepatology
- Epidemiology
Background:
- The association between hepatitis C virus (HCV) infection and peripheral arterial disease (PAD) requires further elucidation.
- HCV is a global health concern with potential systemic implications.
Purpose of the Study:
- To investigate the independent risk of developing PAD in patients with HCV infection.
- To identify factors modifying the risk of PAD in the context of HCV.
Main Methods:
- A retrospective cohort study utilizing health insurance claims data from 1998-2011.
- 7,641 HCV-infected patients were matched with 30,564 controls, excluding those with prior hepatitis B or PAD.
- Multivariate Cox hazard models were employed to assess the adjusted risk of PAD development.
Main Results:
- HCV-infected patients demonstrated a 1.43-fold increased risk of developing PAD compared to controls.
- PAD risk escalated with age, with significantly higher risks observed in older HCV patients.
- Chronic kidney disease/end-stage renal disease and multiple comorbidities substantially elevated PAD risk in HCV patients.
Conclusions:
- HCV infection is an independent risk factor for developing PAD.
- Comorbidities amplify the risk of PAD in HCV-infected individuals, highlighting the need for comprehensive patient management.
Background & Aims:
The relationship between hepatitis C virus (HCV) infection and peripheral arterial disease (PAD) development remains unclear.
Methods:
Health insurance claims data were used to construct a cohort of HCV-infected patients diagnosed during the period 1998-2011. Patients younger than 20 years and those with history of hepatitis B or PAD were excluded. We selected 7641 HCV-infected patients and 30564 matched controls. The adjusted risk of developing PAD was analyzed using a multivariate Cox hazard model.
Results:
The results show that the excess risk of PAD development in HCV-infected patients is 1.43-fold higher (95% CI=1.23-1.67) compared with non-HCV patients. The adjusted risk of PAD development increases with age; compared with the 20-34 year-old patients, the risk is 3.96-fold higher in HCV-infected patients aged 35-49 years, and 11.7-fold higher in those aged 65 years and above. CKD/ESRD has the highest risk for PAD (HR=1.80, 95% CI=1.29-2.53). HCV-infected patients with four comorbidities exhibit a substantially higher risk of developing PAD (HR=9.25, 95% CI=6.35-13.5). Excess risk of developing PAD is observed from the first year of follow-up till the third year.
Conclusion:
HCV-infected patients have an independently higher risk of developing PAD. HCV-infected patients with comorbidity have increased risk of developing PAD.
More Related Videos
Related Concept Videos
Peripheral Artery Disease I: Introduction
Hepatitis
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Peripheral Artery Disease III: Interprofessional Care
Peripheral Artery Disease IV: Nursing Management
Coronary Artery Disease I: Introduction

